34956-29-1

Usage

Uses

Used in Pharmaceutical Industry:
(3-ForMyl-phenyl)-acetic acid is utilized as a key intermediate in the organic synthesis of various pharmaceuticals. Its unique structure allows it to be a building block for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, (3-ForMyl-phenyl)-acetic acid serves as a crucial component in the synthesis of different agrochemicals, contributing to the creation of products that can enhance crop protection and yield.
Used in Organic Chemistry Research:
(3-ForMyl-phenyl)-acetic acid is employed as a valuable compound in organic chemistry research, where it is used to explore new reactions and mechanisms, potentially leading to the discovery of novel organic compounds with diverse applications.
Used in Biological Activity Studies:
Due to its potential anti-inflammatory and analgesic properties, (3-ForMyl-phenyl)-acetic acid is used in biological activity studies to investigate its effects on various biological systems and its potential as a therapeutic agent for conditions such as inflammation and pain.
Used in Cardiovascular and Diabetes Treatment Research:
(3-ForMyl-phenyl)-acetic acid is also being studied for its potential use in the treatment of cardiovascular diseases and diabetes, as researchers explore its possible role in managing or treating these health conditions.

Upstream product

• 158014-92-7 <3-(3-methoxy-3-oxo-1-propenyl)phenyl>acetic acid 
• 142327-44-4 methyl 3-formylphenylacetate 
• 118647-53-3 (3-bromomethyl-phenyl)-acetic acid 
• 210115-24-5 ethyl 2-(3-formylphenyl)acetate 
• 380151-86-0 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarboxaldehyde 
• 3132-99-8 m-bromobenzoic aldehyde 
• 621-36-3 m-methylphenylacetic acid 
• 1878-69-9 3-iodophenylacetic acid 

Downstream Products

• 333389-48-3 N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-3-formylbenzeneacetamide 
• 1098180-67-6 C₂₂H₁₉N₃O₃ 
• 727396-62-5 3-(1H-tetrazol-5-ylmethylaminocarbonylmethyl)-benzaldehyde 
• 1611455-13-0 C₂₇H₂₃Cl₂F₂NO₆ 

Relevant academic research and scientific papers

INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

The present disclosure discloses compounds capable of modulating the activity of α- amino-β-carboxymuconic acid semialdehyde decarboxylase (ACMSD), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in NAD+ biosynthesis, e.g., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application also discloses pharmaceutical compositions comprising said compounds and the use of such compounds as a medicament.

Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure-Activity Relationship Study

Screening of a small compound library at the three excitatory amino acid transporter subtypes 1-3 (EAAT1-3) resulted in the identification of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic aci

OLEFIN SUBSTITUTED OXINDOLES HAVING AMPK ACTIVITY

The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

PHENYLETHYLPYRIDINE DERIVATIVES AS PDE4-INHIBITORS

The invention relates to novel compounds which are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.

NOVEL COMPOUNDS

Compounds of formula (I) defined herein are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract characterized by airway obstruction.

Making imines without making water - exploiting a recognition-mediated Aza-Wittig reaction

(Figure Presented) A recognition-mediated aza-Wittig reaction permits the efficient formation of an imine in dry CDCl3 from an iminophosphorane and an aldehyde. The kinetic and thermodynamic parameters for this reaction are compared with those

SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE

Compounds are provided that are modulators of the C5a receptor. The compounds are substituted dihydropyridines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of C5a receptors.

SYNTHESIS OF A NOVEL MACROCYCLIC LACTONE SYSTEM

A total synthesis of a 14-membered ring lactone (3) with potential biological activity is described.The final lactonization step uses a modification of the Corey pyridinethiol ester procedure.